PCAR
50
-6
TSN
30
-2
BDX
60
6
APA
39
2
AIV
71
4
MSI
50
-8
DNB
56
-2
UPS
53
2
DRI
45
-3
L
55
-3
CHRW
57
7
ZION
60
-3
RF
44
-4
BBY
42
-6
AIZ
68
4
SBUX
41
-3
USB
55
-2
MRK
30
5
HAL
39
-2
LEN
42
-4
PCAR
50
-6
TSN
30
-2
BDX
60
6
APA
39
2
AIV
71
4
MSI
50
-8
DNB
56
-2
UPS
53
2
DRI
45
-3
L
55
-3
CHRW
57
7
ZION
60
-3
RF
44
-4
BBY
42
-6
AIZ
68
4
SBUX
41
-3
USB
55
-2
MRK
30
5
HAL
39
-2
LEN
42
-4
Financhill
Back

Solid Biosciences Vs. Perspective Therapeutics Industry Stock Comparison

Sell
37

SLDB
Solid Biosciences

Last Price:
4.94
Seasonality Move:
34.12%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
22.12%
Sell
37
Solid Biosciences (SLDB) is a Sell

Is Solid Biosciences a Buy, Sell or Hold?

  • The current Solid Biosciences [SLDB] share price is $4.68. The Score for SLDB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • SLDB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SLDB Stock Price Chart

What is Solid Biosciences's stock price today?

  • The Solid Biosciences share price today is $4.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLDB is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.

SLDB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 34.77 Sell
Chaikin Money Flow: -215288 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.97 - 5.71) Sell
Bollinger Bands (100): (5.54 - 8.42) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.72 Sell
Relative Strength Index (14 RSI): 22.27 Sell
Chaikin Money Flow: 378542 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.01 - 8.85) Sell
Bollinger Bands (100): (7.78 - 15.18) Sell

SLDB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.03 Sell
20-day SMA: 5.25 Sell
50-day SMA: 5.74 Sell
200-day SMA: 8.18 Sell
8-day EMA: 5.05 Sell
20-day EMA: 5.28 Sell
50-day EMA: 5.82 Sell
200-day EMA: 7.03 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.69 Sell
20-day SMA: 4.67 Sell
50-day SMA: 9.2 Sell
200-day SMA: 12.39 Sell
8-day EMA: 3.77 Sell
20-day EMA: 5.13 Sell
50-day EMA: 8.02 Sell
200-day EMA: 10.44 Sell

Solid Biosciences Earnings Growth & SLDB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $0.11 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Solid Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):